Announcements Trials

Browse Landscape

Phase

Phase 1 6 Phase 2 5 Phase NA 3 Phase 3 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Hematologic Neoplasms 5 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Leukemia 4 Hodgkin Disease 4 Breast Neoplasms 4 Leukemia, Myeloid, Acute 3 Recurrence 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Sarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphoid 1 Leukemia, Biphenotypic, Acute 1 Inflammatory Breast Neoplasms 1 Hematologic Diseases 1 Graft vs Host Disease 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1

Interventions

Gemcitabine 15 pembrolizumab 13 Doxorubicin 13 Radiotherapy 12 Docetaxel 9 Nivolumab 8 Filgrastim 7 Cyclophosphamide 7 pazopanib 6 Ifosfamide 6 130-nm albumin-bound paclitaxel 5 Temozolomide 4 Irinotecan 4 Ipilimumab 4 Imatinib Mesylate 4 Albumin-Bound Paclitaxel 4 talimogene laherparepvec 3 surufatinib 3 pegfilgrastim 3 eribulin 3 atezolizumab 3 Vinorelbine 3 Sirolimus 3 Peripheral Blood Stem Cell Transplantation 3 PM 01183 3 Drug Therapy 3 Cisplatin 3 toripalimab 2 spartalizumab 2 selinexor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Sarcoma × Mesna × Clear all

NCT00093509 2014-09-01

MRI Sarcoma Non Invasive Thermometry

Duke University

Phase 1/2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡